Creon 10 · DIN 02200104 · 10000 & 33200 & 37500 USP Units · Ent Minimicrosph capsule
Limited Use, Reason for Use code 124, 125, 126, 225 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 124, 125, 126, 225 required
Write on scriptone applicable Reason for Use code, 124 or 125 or 126 or 225 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 124, 125, 126, 225
Reason for Use code 124
Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection).
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 125
Replacement therapy for pancreatic insufficiency due to chronic pancreatitis.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 126
Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 225
Replacement therapy for pancreatic insufficiency due to cystic fibrosis.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Creon 10 · DIN 02200104
Manufacturer: Solvay Pharma Inc.; listing date 1998-12-31
Health Canada: Marketed since 2015-11-20 · brand CREON MINIMICROSPHERES 10 · ATC A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC) · form Capsule (delayed-release) · route Oral · ingredients LIPASE 10000 UNIT, AMYLASE 11200 UNIT, PROTEASE 730 UNIT · company Bgp pharma ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCreon 10: Formulary list price $0.30 per unit (the source does not state the unit; exact figure $0.2954). What the ministry pays, not the patient.
Ministry pays: $0.2954 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02200104)
Source record
DIN 02200104: Creon 10
Raw flags: sec12=Y, sec3=Y
Item: 561600030; group id 660; item number 1645; lccId 00097; manufacturer id SPH
Source form: Ent Minimicrosph Cap; strength: 10000 & 33200 & 37500 USP Units
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.2954; ministry $0.2954
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02200104
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=36179
Shortage status: resolved shortage (ended December 13, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02200104
Shortage record checked October 6, 2026